Dr Reddys Laboratories enters into strategic collaboration with Amgen

To market and distribute three Amgen medicines in India

Dr Reddys Laboratories announced that it has entered into a strategic collaboration with Amgen -one of the world's leading independent biotechnology companies - to market and distribute three Amgen medicines in India in the areas of oncology and cardiology. Under the terms of the collaboration, Dr Reddy's shall perform a full range of regulatory and commercial services to seek approval and launch Kyprolis (carfilzomib), BLINCYTO (blinatumomab) and Repatha (evolocumab) in India.

Powered by Capital Market - Live News